Chemical Research in Toxicology · 2010 · 21 citations · 18 references
Life SciencesBiochemistryChemistryCatalysisEnzymologyOrganic ChemistryDrug-metabolizing EnzymesFlavin-containing MonooxygenasesMetabolite IdentificationReactive Metabolite FormationReactive Oxygen SpeciesAb Initio CalculationsAb Initio Molecular CalculationsFlavin-containing Monooxygenase MetabolismFlavin-containing Monooxygenase PathwaysHuman Flavin-containing MonooxygenasesMammalian Flavin-containing MonooxygenasesReaction Mechanism Elucidation
Here, we report on the mechanism by which flavin-containing monooxygenase 1 (FMO1) mediates the formation of a reactive intermediate of 4-fluoro-N-methylaniline. FMO1 catalyzed a carbon oxidation reaction coupled with defluorination that led to the formation of 4-N-methylaminophenol, which was a reaction first reported by Boersma et al. (Boersma et al. (1993) Drug Metab. Dispos. 21 , 218 - 230). We propose that a labile 1-fluoro-4-(methylimino)cyclohexa-2,5-dienol intermediate was formed leading to an electrophilic quinoneimine intermediate. The identification of N-acetylcysteine adducts by LC-MS/MS and NMR further supports the formation of a quinoneimine intermediate. Incubations containing stable labeled oxygen (H(2)(18)O or (18)O(2)) and ab initio calculations were performed to support the proposed reaction mechanism.
18
Amodiaquine induced agranulocytosis and liver damage.
K Neftel, W Woodtly, M. Schmid et al. · BMJ · 1986 · 292 citations · Full text
Veterinary Medicine, Infectious Diseases, Pharmacotherapy +12
The alpha 1-fetoprotein test in hepatocellular carcinoma.
H. Fox, Athena Kondi, Linsell Ca et al. · PubMed · 1970 · 290 citations
James L. Maggs, Malcolm D. Tingle, N.R. Kitteringham et al. · Biochemical Pharmacology · 1988 · 134 citations